[1]王丹,王养维,李辉,等.2型糖尿病患者动脉粥样硬化病变与血清CTRP3和CTRP9水平的相关性研究[J].现代检验医学杂志,2015,30(06):20-24.[doi:10.3969/j.issn.1671-7414.2015.06.006]
　WANG Dan,WANG Yang-wei,LI Hui,et al.Correlation Research on Atherosclerotic Lesions with Serum CTRP3，CTRP9 Level in Patients with Type 2 Diabetic[J].Journal of Modern Laboratory Medicine,2015,30(06):20-24.[doi:10.3969/j.issn.1671-7414.2015.06.006]
点击复制

2型糖尿病患者动脉粥样硬化病变与血清CTRP3和CTRP9水平的相关性研究()
分享到：

《现代检验医学杂志》[ISSN:/CN:]

卷:
第30卷
期数:
2015年06期
页码:
20-24
栏目:
论著
出版日期:
2015-12-30

文章信息/Info

Title:
Correlation Research on Atherosclerotic Lesions with Serum CTRP3，CTRP9 Level in Patients with Type 2 Diabetic
作者:
王丹; 王养维; 李辉; 李晓华; 张燕
陕西省人民医院内分泌科，西安710068
Author(s):
WANG Dan; WANG Yang-wei; LI Hui; LI Xiao-hua; ZHANG Yan
Department of Endocrinology，Shaanxi Provincial People’s Hospital ，Xi’an 710068，China
关键词:
2型糖尿病; C1q/TNF相关蛋白3; C1q/TNF相关蛋白9; 动脉粥样硬化
分类号:
R587.1；R446.112
DOI:
10.3969/j.issn.1671-7414.2015.06.006
文献标志码:
A
摘要:
目的探讨2型糖尿病(T2DM)患者血清 C1q/TNF 相关蛋白3(C1q tumor necrosis factor related protein 3，CTRP3)，C1q/TNF相关蛋白9(C1q tumor necrosis factor related protein 9，CTRP9)与动脉粥样硬化病变(atherosclerosis，AS)的相关性。方法随机选取2014年1月~2015年1月陕西省人民医院内分泌科住院的成人新发T2DM患者196例，入选T2DM组，并根据颈动脉彩色多普勒超声结果将其分为糖尿病伴动脉粥样硬化组(AS组，71例)和单纯糖尿病组(非AS组，125例)，另外随机选取同期健康体检者152例作为正常对照组，测定所有受试者的体重指数(BMI)，腰围(WC)，臀围(HIP)，腰臀比(WHR)，收缩压(SBP)，舒张压(DBP)，空腹血糖(FBG)，餐后2h血糖(2hPBG)，糖化血红蛋白(HBA1c)，三酰甘油(TG)，总胆固醇(TC)，高密度脂蛋白胆固醇(HDL-C)，低密度脂蛋白胆固醇(LDL-C)，CTRP3及CTRP9。结果①T2DM组血清与正常对照组比较CTRP3(0.67±0.34 ng/ml vs 0.99±0.32 ng/ml)，CTRP9(9.04±3.11 ng/ml vs 12.11±2.89 ng/ml)，HDL-C(1.48±0.27 mmol/L vs 1.23±0.57 mmol/L)，FBG(4.62±0.53 mmol/L vs 9.41±2.61 mmol/L)，2hPBG(5.90±0.80 mmol/L vs 11.55±3.20 mmol/L)，HBA1c(4.86±0.45 mmol/L vs 8.79±2.14 mmol/L)，LDL-C(2.48±0.36 mmol/L vs 3.58±0.89 mmol/L)，TC(3.64±1.10 mmol/L vs 5.77±0.97 mmol/L)，TG(1.23±0.34 mmol/L vs 1.71±0.75 mmol/L)差异有统计学显著性意义(t=-13.069~5.88，P值均<0.01)。②AS组与非AS组比较CTRP3(0.67±0.34 ng/ml vs 0.99±0.32 ng/ml)，CTRP9(9.04±3.11 ng/ml vs 12.11±2.89 ng/ml)，年龄(55.82±8.80岁 vs 62.49±6.54岁)差异有统计学显著性意义(t/χ2=0.036~7.345，P值均<0.01)，两组血清TC(5.61±0.90 mmol/L vs 6.05±1.02 mmol/L)，LDL-C(3.44±0.80 mmol/L vs 3.83±1.01 mmol/L)差异亦有统计学显著性意义(t=-2.083~-2.197，P值均<0.05)。③相关性研究：CTRP3与WC(r=-0.932)，DBP(r=-0.932)，FBG(r=-0.856)，TG(r=-0.728)，TC(r=-0.920)呈负相关(P值均<0.01)，CTRP9和年龄(r=-0.958)呈负相关(P值均<0.01)，与HDL-C(r=0.860)呈正相关(P<0.01)。④多元逐步回归分析：WC，DBP，FBG是CTRP3的独立危险因子(P<0.01)，年龄，HDL-C是CTRP9的独立危险因子(P<0.01)。结论CTRP3，CTRP9可能具有抗动脉粥样硬化作用，是糖尿病动脉粥样硬化的保护因子。
Abstract:
ObjectiveTo explore the reletionship between C1q/TNF-related protein-3 (CTRP3)，C1q/TNF-related protein-9 (CTRP9) and artery atherosclerosis (AS) in the patients with type 2 diabetes (T2DM)．MethodsCollected clinical datas of adults with patients with new type 2 diabetic who were in endocrinology department of Shaanxi Provincial People’s Hospital from January 2014 to January 2015 enrolled 196 cases of T2DM group，and according to the results of carotid color Doppler ultrasound were divided into diabetic patients with atherosclerosis group (AS group，71 cases) and diabetes alone group (non-AS group，125 cases)，and then randomly selected 152 cases of healthy volunteers as normal control group，all subjects measured body mass index (BMI)，waist circumference (WC)，hip circumference (HIP)，waist-hip ratio (WHR)，systolic blood pressure (SBP)，diastolic blood pressure (DBP)，fasting blood glucose (FBG)，2-hour postprandial blood glucose (2hPBG)，glycated hemoglobin (HBA1c)，triglycerides (TG)，total cholesterol (TC)，high density lipoprotein cholesterol (HDL-C)，low-density lipoprotein cholesterol (LDL-C)，CTRP3 and CTRP9．Results①The difference of serum CTRP3 (0.67±0.34 ng/ml vs 0.99±0.32 ng/ml)，CTRP9 (9.04±3.11 ng/ml vs 12.11±2.89 ng/ml)，HDL-C (1.48±0.27 mmol/L vs 1.23±0.57 mmol/L)，FBG (4.62±0.53 mmol/L vs 9.41±2.61 mmol/L)，2hPBG (5.90±0.80 mmol/L vs 11.55±3.20 mmol/L)，HBA1c (4.86±0.45 mmol/L vs 8.79±2.14 mmol/L)，LDL (2.48±0.36 mmol/L vs 3.58±0.89 mmol/L)，TC (3.64±1.10 mmol/L vs 5.77±0.97 mmol/L)，TG (1.23±0.34 mmol/L vs 1.71±0.75 mmol/L)(t=-13.069~5.88，P all<0.01) in T2DM group and normal control group were significant．②The difference of serum CTRP3 (0.67±0.34 ng/ml vs 0.99±0.32 ng/ml)，CTRP9 (9.04±3.11 ng/ml vs 12.11±2.89 ng/ml)，the age (55.82±8.80 year vs 62.49±6.54 year)(t/χ2=0.036~7.345，P all<0.01)，TC (5.61±0.90 mmol/L vs 6.05±1.02 mmol/L)，LDL-C (3.44±0.80 mmol/L vs 3.83±1.01 mmol/L)(t=-2.083~-2.197，P all<0.05) in T2DM group and non-AS group were significant．Serum levels of TC (5.61±0.90 mmol/L vs 6.05±1.02 mmol/L)，LDL-C (3.44±0.80 mmol/L vs 3.83±1.01 mmol/L) difference were also statistically significant (t=-2.083~-2.197，P all<0.05)．③CTRP3 negatively correlated with WC (r=-0.932)，DBP (r=-0.932)，FBG (r=-0.856)，TG (r=-0.728)，TC (r=-0.920)(P<0.01)，CTRP9 negatively correlated with age (r=-0.958)，positively correlated with HDL-C (r=0.860)(P<0.01)．④Multiple Stepwise regression analysis showed that WC，DBP，FBG would be independent risk factors of CTRP3 (P<0.01) and the age，HDL-C would be independent risk factors of CTRP9 (P<0.01)．ConclusionCTRP3，CTRP9 may have anti-atherosclerotic effect，is diabetic atherosclerosis protection factor．

参考文献/References:

［1］Yuan Y，Gao E，Wang Y，et al．CTRPs，a novel therapeutic target against myocardial ischemia/reperfusion injury［J］．Circulation，2010，122(21 Supplement)：A14133．
[2]Look AHEAD Research Group，Wing RR，Bolin P，et al．Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes［J］．The New England Journal of Medicine，2013，369(2)：145-154．
[3]Barzilay JI，Mukamal KJ，Kizer JR．Atherosclerotic cardiovascular disease in older adults with diabetes mellitus［J］．Clinics in Geriatric Medicine，2015，31(1)：29-39．
[4]Beckman JA，Creager MA，Libby P．Diabetes and atherosclerosis：epidemiology，pathophysiology，and management［J］．JAMA，2002，287(19)：2570-2581．
[5]沈亚梅，邹荣莉，邱英武，等．糖尿病前期患者血管内皮舒张功能与血脂关系的超声研究［J］．现代检验医学杂志，2008，23(3)：78-80． Shen YM，Zou RL，Qiu YW，et al．Evaluation of correlations between endothelial dilation function and blood lipid in patients on the stage before diabetes via ultrasonography［J］．J Mod Lab Med，2008，23(3)：78-80．
[6]Bornfeldt KE．2013 Russell ross memorial lecture in vascular biology:cellular and molecular mechanisms of diabetes mellitus-accelerated atherosclerosis［J］．Arteriosclerosis Thrombosis and Vascular Biology，2014，34(4)：705-714．
[7]Wong GW，Wang J，Hug C，et al．A family of Acrp30/adiponectin structural and functional paralogs［J］．Proc Natl Acad Sci USA，2004，101(28)：10302-10307．
[8]Ahima RS，Qi Y，Singhal NS，et al．Brain adipocytokine action and metabolic regulation［J］．Diabetes，2006，55(Suppl 2)：S145-S154．
[9]Huang Z，Cui T，Liu J，et al．Characterization of the expression of CTRP9，a paralog of adiponectin［J］．Tsinghua Science & Technology，2008，13(4)：492-499．
[10]Peterson JM，Wei Z，Wong GW．C1q/TNF-related protein-3(CTRP3)，a novel adipokine that regulates hepeatic glucose output［J］．J Biol Chem，2010，285(51)：39691-39701．
[11]张小平，崔曦沁．2型糖尿病患者血Fbg，HCRP及脂类水平的测定与意义［J］．现代检验医学杂志，2006，21(4)：79-80． Zhang XP，Cui XQ．Type 2 diabetes patients with blood Fbg，HCRP and lipid levels［J］．J Mod Lab Med，2006，21(4)：79-80．
[12]Maeda T，Wakisaka S．CTRP3/cartducin is induced by transforming growth factor-β1 and promotes vascular smooth muscle cell proliferation［J］．Cell Biology International，2010，34(3)：261-266．
[13]Weigert J，Neumeier M，Schffler A，et al．The adiponectin paralog CORS-26 has anti-inflammatory properties and is produced by human monocytic cells［J］．FEBS letters，2005，579(25)：5565-5570．
[14]Weisberg SP，McCann D，Desai M，et al．Obesity is associated with macrophage accumulation in adipose tissue［J］．Journal of Clinical Investigation，2003，112(12)：1796-1808．
[15]Uemura Y，Shibata R，Ohashi K，et al．Adipose-derived factor CTRP9 attenuates vascular smooth muscle cell proliferation and neointimal formation［J］．FASEB J，2013，27(1)：25-33．
[16]王瑾瑜，周允，冯寒，等．脂肪因子CTRP3促进血管钙化机制研究［J］．中国病理生理杂志，2012，11(1)：2033． Wang JY，Zhou Y，Feng H，et al．Study vascular calcification mechanism adipokines CTRP3 promoted［J］．Chinese Journal of Pathophysiology，2012，11(1)：2033．
[17]Akiyama H，Furukawa S，Wakisaka S，et al．Cartducin stimulates mesenchymal chondroprogenior cell proliferation through both extracellular signal-regulated kinase and phosphatidylinosito1 3 kinase／Akt pathways［J］．FEBS J，2006，273(10)：2257-2263．
[18]Akiyama H，Furukawa S，Wakisaka S，et al．Elevated expression of CTRP3／cartducin contributes to promotion of osteosarcoma cell proliferation［J］．Oncol Rep，2009，21(6)：1477-1481．
[19]Akiyama H，Furukawa S，Wakisaka S，et al．CTRP3／cartducin promotes proliferation and migration of endothelial cells［J］．Mol Cell Biochem，2007，304(1/2)：243-248．
[20]Ma K，Cabrero A，Saha PK，et al．Increased beta-oxidation but no insulin resistance or glucose intolerance in mice lacking adiponectin［J］．J Biol Chem，2002，277(38)：34658-34661．
[21]Peterson M，Wei Z，Wong GW．C1q/TNF-related protein-3(CTRP3)，a novel adipokine that regulates hepatic glucose output［J］．J Biol Chem，2010，285(51)：39691-39701．
[22]Uemura Y，Shibata R，Ohashi K，et al．Adipose-derived factor CTRP9 attenuates vascular smooth muscle cell proliferation and neointimal formation［J］．The FASEB Journal，2013，27(1)：25-33．
[23]Zheng Q，Yuan Y，Yi W，et al．C1q/TNF-related proteins，a family of novel adipokines，induce vascular relaxation through the adiponectin receptor-1/AMPK/eNOS/nitric oxide signaling pathway［J］．Arteriosclerosis Thrombosis and Vascular Biology，2011，31(11)：2616-2623．
[24]Wong GW，Krawczyk SA，Kitidis-Mitrokostas C，et al．Identification and characterization of CTRP9，a novel secreted glycoprotein，from adipose tissue that reduces serum glucose in mice and forms heterotrimers with adiponectin［J］．The FASEB Journal，2009，23(1)：241-258．

相似文献/References:

[1]张曙晴a,李洪彬b,张骆军a,等.2型糖尿病患者糖化血红蛋白水平与胰岛素分泌及胰岛素抵抗的关系[J].现代检验医学杂志,2016,31(02):108.[doi:10.3969/j.issn.1671-7414.2016.02.032]
　ZHANG Shu-qinga,LI Hong-binb,ZHANG Luo-juna,et al.Correlation between Insulin Secretion,Insulin Resistance and Glycosylated Hemoglobin Levels in Patients with Type 2 Diabetic[J].Journal of Modern Laboratory Medicine,2016,31(06):108.[doi:10.3969/j.issn.1671-7414.2016.02.032]
[2]蔡加炉,王 成,汪俊军.循环微小核糖核酸与2型糖尿病的关系[J].现代检验医学杂志,2015,30(03):5.[doi:10.3969/j.issn.1671-7414.2015.03.002]
　CAI Jia-lu,WANG Cheng,WANG Jun-jun.Relationship between Circulating miRNA and Type 2 Diabetes[J].Journal of Modern Laboratory Medicine,2015,30(06):5.[doi:10.3969/j.issn.1671-7414.2015.03.002]
[3]段发兰a,李亚新b,杨飞翔a,等.2型糖尿病患者血清铁代谢相关指标检测意义[J].现代检验医学杂志,2015,30(03):151.[doi:10.3969/j.issn.1671-7414.2015.03.046]
　Study on Iron Metabolism in Type Diabetes Patients.Study on Iron Metabolism in Type 2 Diabetes Patients[J].Journal of Modern Laboratory Medicine,2015,30(06):151.[doi:10.3969/j.issn.1671-7414.2015.03.046]
[4]吴晓康,马超峰,余鹏博,等.2型糖尿病患者肠道菌群两种分子指纹图谱分析研究[J].现代检验医学杂志,2015,30(04):24.[doi:10.3969/j.issn.1671-7414.2015.04.006]
　WU Xiao-kang,MA Chao-feng,YU Peng-bo,et al.Analysis of Intestinal Microbiota of Type 2 Diabetes Patients of by Two Fingerprint Technologies[J].Journal of Modern Laboratory Medicine,2015,30(06):24.[doi:10.3969/j.issn.1671-7414.2015.04.006]
[5]张阳东a,陈洁b,楚瑞雪,等.2型糖尿病患者低密度脂蛋白水平及其受体基因表达水平研究[J].现代检验医学杂志,2015,30(05):97.[doi:10.3969/j.issn.1671-7414.2015.05.029]
　ZHANG Yang-donga,CHEN Jieb,CHU Rui-xue,et al.Study on Low-density Lipoprotein Levels and It’s Receptor Genes Expression Levels in Type 2 Diabetes Mellitus Patients[J].Journal of Modern Laboratory Medicine,2015,30(06):97.[doi:10.3969/j.issn.1671-7414.2015.05.029]
[6]李全双,邓演超,吴 燕,等.初诊2型糖尿病患者综合干预后血栓前状态分子标志物的变化[J].现代检验医学杂志,2015,30(02):36.[doi:10.3969/j.issn.1671-7414.2015.02.011]
[7]叶永红,陈月兰,詹禧奎,等.联合检测Ficolin-3,TRF及hs-CRP对2型糖尿病早期诊断价值[J].现代检验医学杂志,2016,31(04):74.[doi:10.3969/j.issn.16717-414.2016.04.019]
　YE Yong-hong,CHEN Yue-lan,ZHAN Xi-kui,et al.Early Diagnostic Value of Combined Detection of Ficolin-3, TRF and hs-CRP for Type 2 Diabetes[J].Journal of Modern Laboratory Medicine,2016,31(06):74.[doi:10.3969/j.issn.16717-414.2016.04.019]
[8]万淑君,王 成,王 静,等.2型糖尿病微血管并发症患者血清miR-16,miR-126和miR-221水平检测及临床意义[J].现代检验医学杂志,2016,31(05):9.[doi:10.3969/j.issn.1671-7414.2016.05.003]
　WAN Shu-jun,WANG Cheng,WANG Jing,et al.Study on Serum Levels of miR-16,miR-126 and miR-221 and Their Clinical Significance in Type 2 Diabetes Patients with or Without Microvascular Complications[J].Journal of Modern Laboratory Medicine,2016,31(06):9.[doi:10.3969/j.issn.1671-7414.2016.05.003]
[9]朱影明,许新强,周 强,等.广东地区2型糖尿病与抵抗素基因位点rs2161490和rs1423096多态性的相关性研究[J].现代检验医学杂志,2017,32(01):48.[doi:10.3969/j.issn.1671-7414.2017.01.014]
　ZHU Ying-ming,XU Xin-qiang,ZHOU Qiang,et al.Correlation Study between Resistin rs2161490 and rs1423096 and Type 2 Diabetes Mellitus[J].Journal of Modern Laboratory Medicine,2017,32(06):48.[doi:10.3969/j.issn.1671-7414.2017.01.014]
[10]郭宜晨,鲁亚静,钟伟传,等.2型糖尿病患者外周血miRNA表达谱差异研究[J].现代检验医学杂志,2018,33(06):5.[doi:10.3969/j.issn.1671-7414.2018.06.002]
　GUO Yi-chen,LU Ya-jing,ZHONG Wei-chuan,et al.Study on the Difference of Serum miRNA Expression Profile in Peripheral Blood of Patients with Type 2 Diabetes Mellitus[J].Journal of Modern Laboratory Medicine,2018,33(06):5.[doi:10.3969/j.issn.1671-7414.2018.06.002]

备注/Memo

备注/Memo:
作者简介：王丹(1990-)，女，硕士研究生，研究方向：内分泌及代谢病学，Tel：15529508182，E-mail：15529508182@163.com。 通讯作者：王养维(1961-)，男，硕士，主任医师，研究方向：内分泌及代谢病学，Tel：13991930381，E-mail：wangyangwei1068@126.com。
更新日期/Last Update: 1900-01-01